Gary Lee Feiss
Plus aucun poste en cours
Profil
Gary Lee Feiss held positions as Director of Clinical Trials at OraSure Technologies, Vice President of Regulatory Affairs at Covalent Group, and VP of Clinical Development & Regulatory Affairs at Saladax Biomedical.
Anciens postes connus de Gary Lee Feiss
| Sociétés | Poste | Fin |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
| Covalent Group, Inc. | Conseiller Juridique Général | - |
Saladax Biomedical, Inc.
 Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Conseiller Juridique Général | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Saladax Biomedical, Inc.
Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Commercial Services |
| Covalent Group, Inc. | Commercial Services |
